Impero (IMPERO) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
27 Jul, 2026Executive summary
Achieved strong ARR growth of 28% year-over-year, reaching DKK 38.7M in 2024, with continued traction in German-speaking markets and across multiple sectors.
Significant reduction in cash burn relative to net new ARR, aligning with strategic direction and improving operational efficiency.
Strengthened organization with new CTO and CCO appointments, and accelerated product development cycles leading to new upsell opportunities.
Financial highlights
Revenue increased by 28% to DKK 35.4M in 2024 compared to DKK 27.6M in 2023.
Gross profit margin remained strong at 97% in 2024.
EBITDA improved to DKK -8.7M in 2024 from DKK -10.6M in 2023, exceeding original outlook.
Cash position at year-end was DKK 9.8M, with improved cash flow from operating activities (negative DKK 4.3M vs. negative DKK 8.4M in 2023).
Outlook and guidance
2025 ARR guidance set at DKK 46M to 52M, representing 19% to 34% growth.
2025 EBITDA expected between DKK -10M and DKK -8M.
Strategic goal to double customer base and achieve recurring cash flow positivity before end of 2026.
Latest events from Impero
- 28% ARR and 29% revenue growth, improved EBITDA, and strong DACH expansion in H1 2024.IMPERO
Q2 202427 Jul 2026 - 31% ARR growth, strong retention, and positive cash flow highlight robust Q3 performance.IMPERO
Q3 202427 Jul 2026 - 24% ARR growth, 27% revenue rise, and strong retention highlight robust Q1 2025 performance.IMPERO
Q1 202527 Jul 2026 - ARR up 15% to DKK 40.7M, revenue up 21%, EBITDA loss narrows, guidance maintained.IMPERO
Q2 202527 Jul 2026 - Record ARR growth, positive EBITDA, and strong DACH performance drive raised 2025 outlook.IMPERO
Q3 202527 Jul 2026 - ARR grew 19% to DKK 46.2M in 2025, with EBITDA improving and churn at a low 1%.IMPERO
Q4 202527 Jul 2026 - 20% ARR growth, positive EBITDA, and strong DACH momentum drive upgraded 2026 outlook.IMPERO
Q1 202627 Jul 2026 - Entity Management, AI features, and Control Health drive upcoming platform enhancements.IMPERO
Investor update24 Jun 2026 - Strong ARR growth, AI-driven strategy, and all board proposals approved amid market uncertainties.IMPERO
AGM 202615 Apr 2026